Acadia Pharma Q4 2024 Earnings Preview

by
Contributor since / Followers

2 months ago

Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q4 earnings results on Wednesday, February 26th, after market close.
The consensus EPS Estimate is $0.22 and the consensus Revenue Estimate is $273.04M (+18.2% Y/Y).
Over the last 3 months, EPS estimates have seen

Tags: ACAD